The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11150 malaria professionals are enjoying the free benefits of MalariaWorld today

hlorproguanil–Dapsone

Chlorproguanil–Dapsone–Artesunate versus Chlorproguanil–Dapsone: A Randomized, Double-Blind, Phase III Trial in African Children, Adolescents, and Adults with Uncomplicated Plasmodium falciparum Malaria

December 18, 2009 - 16:14 -- Ingeborg van Schayk
Tags: 
Author(s): 
Alfred B. Tiono, Alassane Dicko, Dennis A. Ndububa, Tsiri Agbenyega, Simon Pitmang, Jacob Awobusuyi, Allan Pamba, Stephan Duparc, Li-Ean Goh, Emma Harrell, Nick Carter, Stephen A. Ward, Brian Greenwood, AND Peter A. Winstanley
Reference: 
Am J Trop Med Hyg 2009;81 969-978

This multi-center, randomized, parallel-group, double-blind, double-dummy study compared the efficacy and safety of chlorproguanil–dapsone–artesunate (CDA) and chlorproguanil–dapsone (CPG–DDS) in the treatment of falciparum malaria in Africa (Burkina Faso, Ghana, Mali, Nigeria).

Continent: 
Subscribe to RSS - hlorproguanil–Dapsone